Should a patent be invalidated if a company intentionally misled the patent office to get it?
That question is driving a multi-million dollar lobbying war in D.C., as drug makers and other patent-centric companies fight over the “inequitable conduct” rules of federal patent law, the NYT reports.
The current rules, under which patents are regularly revoked for [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment